Pharmanovia launches OsteoApp, creating new ways to improve the management of osteoporosis

Basildon (UK), 8 September 2021 – Pharmanovia, the original medicines specialist globally, in conjunction with their South African partner Adcock Ingram, has launched OsteoApp, a medication app reminder for patients that is aimed at improving the management of osteoporosis.

Bonviva®/Boniva®* tablets have an advantage over other osteoporosis treatments for being a once-monthly oral treatment. We developed OsteoApp to help remind patients when to take their medication, including when they need to contact their healthcare professionals for a repeat prescription.

Other features on OsteoApp include:

•           Instructional Video – A quick video, showing patients how to take the medication.

•           Patient guide – An easy-to-understand patient guide.

•           Tips on healthy eating, that will regularly be updated and pushed through to users.

•           Extra information such as links to various support groups.

Speaking about the launch of OsteoApp, Dr Amit Patel, Pharmanovia’s CEO said, “We are very proud to be working with Adcock Ingram in South Africa, to launch our new app. Pharmanovia is not only about delivering high-quality branded prescription medicines.  Our goal is to go, over and above for all our partners, patients, prescribers and healthcare providers across the globe.  The development of OsteoApp shows our commitment to investing and progressing iconic medicines.”

Regarding the app, Lize Ferreira, Business Unit Manager for Women’s Health at Adcock Ingram said, “We are very excited to launch the OsteoApp with Pharmanovia. As leaders in the South African osteoporosis market, it gives us an opportunity to enhance patient compliance. Adcock Ingram is committed to offering a broad range of quality and affordable medicines in specific therapeutic areas for patients consulting healthcare professionals. The burden of osteoporotic fractures is significant and increasing, and drugs available to treat the burden of fractures are compromised by poor adherence as well as rising costs. We believe that the OsteoApp will increase patient adherence and ultimately add value to patients’ lives – which is our purpose at Adcock Ingram”

OsteoApp will also be launched in Mexico and South Korea later in the year.   

*registered trademark in South Africa

—ends—

About Adcock Ingram

Adcock Ingram is a leading South African pharmaceutical manufacturer, founded in 1891, and listed on the Johannesburg Stock Exchange.  Adcock Ingram manufactures, markets and distributes a wide range of healthcare and consumer products, and is a leading supplier to both the private and public sectors of the market.  Adcock Ingram provides an extensive portfolio of branded and generic medicines. It also has a strong presence in over the counter brands and is South Africa’s largest supplier of hospital and critical care products. The Company’s mission is to provide quality products that improve the health and lives of the people in the markets that we serve.

www.adcock.com

About Pharmanovia – The original medicines specialist globally

Our purpose is to progress iconic medicines for the benefit of patient health globally.

We provide iconic, tried and trusted medicines in the strategic therapeutic areas of Cardiovascular, Women’s Health & Endocrinology, Neurology & Pain, and Gastroenterology & Oncology. We own some of the world’s most recognisable brands, including Bonviva®, Inderal®, Kytril®, Naprosyn®, Valium®, Zestril® and more.  We operate a portfolio of 20+ brands in 140+ markets with over 200 employees, and we grow through development, licensing and acquisition.